Abstract
Basal cell carcinoma is the most common skin cancer for which surgery is usually the unique and definitive treatment. Advanced basal cell carcinoma is not eligible to surgery when underlying structures are destroyed. Delayed consultation is the principal cause of advanced basal cell carcinoma. It is questionable why some patients seek care only when the tumour is advanced. The objective of this study was to identify the psychosocial factors involved in delayed consultation. We used a qualitative approach, conducting semi-structured interviews with advanced basal cell carcinoma patients and the healthcare staff of a dermatology unit to explore why some patients consult only when basal cell carcinoma is advanced. We then put our findings into perspective and created a logical model for change. We interviewed 14 patients and 12 healthcare staff. The first lesion was associated with banalization. Then, denial and fear of diagnosis or treatment were post common. Finally, the advanced basal cell carcinoma’s symptoms, along with social pressure, created the intention to seek medical help and improved disease awareness. We developed a logical model that summarizes these findings. In this pilot study, we modelled factors that delayed consultation. This will aid future research and targeted interventions reducing delay, in particular by improving knowledge and by using social pressure as facilitators. Trial registration: NCT04124796.
Similar content being viewed by others
References
Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069–1080
Jacobsen AA, Aldahan AS, Hughes OB, Shah VV, Strasswimmer J (2016) Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies. JAMA Dermatol 152:816–824
Safer MA, Tharps QJ, Jackson TC, Leventhal H (1979) Determinants of three stages of delay in seeking care at a medical clinic. Med Care 17:11–29
de Vries H (2017) An integrated approach for understanding health behavior; the I-change model as an example. PBSI J 2:1–8
Chojnacka-Szawłowska G, Kościelak R, Karasiewicz K, Majkowicz M, Kozaka J (2013) Delays in seeking cancer diagnosis in relation to beliefs about the curability of cancer in patients with different disease locations. Psychol Health 28:154–170
Alam M, Goldberg LH, Silapunt S et al (2011) Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 64:839–848
Renzi C, Mastroeni S, Mannooranparampil TJ, Passarelli F, Pasquini P (2011) Timely diagnosis of cutaneous squamous cell carcinoma: The GP’s role. Fam Pract 28:277–279
Yancovitz M, Rizzo C, Julian P, Oliveria SA, Becker D (2013) Patient perceptions of nonmelanoma skin cancer before diagnosis. Dermatol Surg 39:1496–1501
Kakagia D, Trypsiannis G, Karanikas M, Mitrakas A, Lyratzopoulos N, Polychronidis A (2013) Patient-related delay in presentation for cutaneous squamous cell carcinoma a cross-sectional clinical study. Onkologie 36:738–744
Ristvedt SL, Trinkaus KM (2005) Psychological factors related to delay in consultation for cancer symptoms. Psycho-Oncology 14:339–350
Husein-ElAhmed H, Gutierrez-Salmeron MT, Naranjo-Sintes R, Aneiros-Cachaza J (2013) Factors related to delay in the diagnosis of basal cell carcinoma. J Cutan Med Surg 17:27–32
Spring B (2007) Evidence-based practice in clinical psychology: What it is, why it matters; what you need to know. J Clin Psychol 63:611–631
Amici JM, Battistella M, Beylot-Barry M et al (2015) Defining and recognising locally advanced basal cell carcinoma. Eur J Dermatol 25:586–594
Prochaska JO, Di Clemente CC (1997) Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51:390–395
Robinson JK, Altman JS, Rademaker AW (1995) Socioeconomic status and attitudes of 51 patients with giant basal and squamous cell carcinoma and paired controls. Arch Dermatol 131:428–431
Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366:825–831
Sparsa A, Doffoel-Hantz V, Durox H et al (2012) Tumeur maligne historique: 27 case. Ann Dermatol Vener 139:189–193
Körner A, Garland R, Czajkowska Z, Coroiu A, Khanna M (2016) Supportive care needs and distress in patients with non-melanoma skin cancer: Nothing to worry about? Eur J Oncol Nurs 20:150–155
Radiotis G, Roberts N, Czajkowska Z, Khanna M, Körner A (2014) Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress. Oncol Nurs Forum 41:57–65
Henderson JG (2006) Denial and repression as factors in the delay of patients with cancer presenting themselves to the physician. Ann NY Acad Sci 125:856–864
Kannan VD, Veazie PJ (2014) Predictors of avoiding medical care and reasons for avoidance behavior. Med Care 52:336–345
Zehou O, Valeyrie-Allanore L, Ortonne N et al (2012) Tumeurs « historiques »: tumeurs négligées trois observations. Ann Dermatol Venereol 139:194–198
Reader TW, Gillespie A (2013) Patient neglect in healthcare institutions: a systematic review and conceptual model. BMC Health Serv Res 13:156–171
Kasparian NA, McLoone JK, Meiser B (2009) Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med 32:406–428
Blackford S, Roberts D, Salek MS, Finlay A (1996) Basal cell carcinomas cause little handicap. Qual Life Res 5:191–194
Acknowledgments
We thank Christine Alfaro Coordinator Research Assistant and the medical doctors who participated in the inclusion of patients: Prof. Anne Pham-Ledard and Drs Emilie Gerard, Léa Dousset, Sorilla Prey, and Caroline Dutriaux. We thank all the patients and healthcare staff who participated in this study. Editing: We thank Textcheck and Richard Turner for professional editing of the English (certificate: http://www.textcheck.com/certificate/BK9mHA).
Funding
This work received research funding from French Society of Dermatology and the French Cancer League. These funding organizations had no role in design and conduction of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
All the authors had full access to all the data in the study. CG, MB-B, and BQ took responsibility for the integrity of the data and the accuracy of the data analysis. CG and MB-B wrote the manuscript. BQ, GB and AL reviewed the paper and provided important advice. All authors, especially CG, BQ, and GB, participated in elaboration of semi-structured interview guides.
Corresponding author
Ethics declarations
Conflicts of interest
None to declare.
Ethic approval
The work was approved by Health Service Research Ethics Committee (approval no. IRCB 2018-A00200-55), the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), and the Commission Nationale de l’Informatique et des Libertés (CNIL No. 2167944).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Garrouteigt, C., Broc, G., Legrand, A. et al. Facilitators of and obstacles to consultation in patients with advanced basal cell carcinoma: a French pilot study. Arch Dermatol Res 313, 829–835 (2021). https://doi.org/10.1007/s00403-020-02175-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-020-02175-x